Literature DB >> 23609465

Colorectal cancer: Update on the clinical management of Lynch syndrome.

Henry T Lynch1, Patrick M Lynch.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23609465     DOI： 10.1038/nrgastro.2013.70

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  10 in total

1.  Surveillance for hereditary nonpolyposis colorectal cancer: a long-term study on 114 families.

Authors:  Wouter H de Vos tot Nederveen Cappel; Fokko M Nagengast; Gerrit Griffioen; Fred H Menko; Babs G Taal; Jan H Kleibeuker; Hans F Vasen
Journal:  Dis Colon Rectum       Date:  2002-12       Impact factor: 4.585

2.  Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer.

Authors:  H J Järvinen; J P Mecklin; P Sistonen
Journal:  Gastroenterology       Date:  1995-05       Impact factor: 22.682

3.  Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery.

Authors:  Susan Parry; Aung Ko Win; Bryan Parry; Finlay A Macrae; Lyle C Gurrin; James M Church; John A Baron; Graham G Giles; Barbara A Leggett; Ingrid Winship; Lara Lipton; Graeme P Young; Joanne P Young; Caroline J Lodge; Melissa C Southey; Polly A Newcomb; Loïc Le Marchand; Robert W Haile; Noralane M Lindor; Steven Gallinger; John L Hopper; Mark A Jenkins
Journal:  Gut       Date:  2010-12-30       Impact factor: 23.059

4.  Causes of death of mutation carriers in Finnish Lynch syndrome families.

Authors:  Kirsi Pylvänäinen; Tuula Lehtinen; Ilmo Kellokumpu; Heikki Järvinen; Jukka-Pekka Mecklin
Journal:  Fam Cancer       Date:  2012-09       Impact factor: 2.375

5.  Health benefits and cost-effectiveness of primary genetic screening for Lynch syndrome in the general population.

Authors:  Tuan A Dinh; Benjamin I Rosner; James C Atwood; C Richard Boland; Sapna Syngal; Hans F A Vasen; Stephen B Gruber; Randall W Burt
Journal:  Cancer Prev Res (Phila)       Date:  2010-11-18

6.  Cancer: Lynch syndrome--how should colorectal cancer be managed?

Authors:  Hans F A Vasen; Wouter H de Vos tot Nederveen Cappel
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-04       Impact factor: 46.802

7.  Prediction of MLH1 and MSH2 mutations in Lynch syndrome.

Authors:  Judith Balmaña; David H Stockwell; Ewout W Steyerberg; Elena M Stoffel; Amie M Deffenbaugh; Julia E Reid; Brian Ward; Thomas Scholl; Brant Hendrickson; John Tazelaar; Lynn Anne Burbidge; Sapna Syngal
Journal:  JAMA       Date:  2006-09-27       Impact factor: 56.272

8.  Chromocolonoscopy detects more adenomas than white light colonoscopy or narrow band imaging colonoscopy in hereditary nonpolyposis colorectal cancer screening.

Authors:  R Hüneburg; F Lammert; C Rabe; N Rahner; P Kahl; R Büttner; P Propping; T Sauerbruch; C Lamberti
Journal:  Endoscopy       Date:  2009-04-01       Impact factor: 10.093

9.  Carrier risk status changes resulting from mutation testing in hereditary non-polyposis colorectal cancer and hereditary breast-ovarian cancer.

Authors:  P Watson; S A Narod; R Fodde; A Wagner; J F Lynch; S T Tinley; C L Snyder; S A Coronel; B Riley; Y Kinarsky; H T Lynch
Journal:  J Med Genet       Date:  2003-08       Impact factor: 6.318

10.  Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts.

Authors:  Hans F A Vasen; Ignacio Blanco; Katja Aktan-Collan; Jessica P Gopie; Angel Alonso; Stefan Aretz; Inge Bernstein; Lucio Bertario; John Burn; Gabriel Capella; Chrystelle Colas; Christoph Engel; Ian M Frayling; Maurizio Genuardi; Karl Heinimann; Frederik J Hes; Shirley V Hodgson; John A Karagiannis; Fiona Lalloo; Annika Lindblom; Jukka-Pekka Mecklin; Pal Møller; Torben Myrhoj; Fokko M Nagengast; Yann Parc; Maurizio Ponz de Leon; Laura Renkonen-Sinisalo; Julian R Sampson; Astrid Stormorken; Rolf H Sijmons; Sabine Tejpar; Huw J W Thomas; Nils Rahner; Juul T Wijnen; Heikki Juhani Järvinen; Gabriela Möslein
Journal:  Gut       Date:  2013-02-13       Impact factor: 23.059
  10 in total
  3 in total

1.  Epithelial-mesenchymal transition in colorectal cancer tissue of patients with Lynch syndrome.

Authors:  Guo-Li Gu; Xiao-Quan Zhu; Xue-Ming Wei; Li Ren; De-Chang Li; Shi-Lin Wang
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

Review 2.  The unpluggable in pursuit of the undruggable: tackling the dark matter of the cancer therapeutics universe.

Authors:  Richard J Epstein
Journal:  Front Oncol       Date:  2013-12-12       Impact factor: 6.244

3.  MMR Deficiency Does Not Sensitize or Compromise the Function of Hematopoietic Stem Cells to Low and High LET Radiation.

Authors:  Rutulkumar Patel; Yulan Qing; Lucy Kennedy; Yan Yan; John Pink; Brittany Aguila; Amar Desai; Stanton L Gerson; Scott M Welford
Journal:  Stem Cells Transl Med       Date:  2018-04-14       Impact factor: 6.940
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.